708 research outputs found

    'Loss of control' in alcoholism and drug addiction:A neuroscientific interpretation

    Get PDF

    An investigation into the effects of methadone on cognitive and psychomotor function, mood, concentration and craving.

    Get PDF
    Methadone is a synthetic opioid that produces cross-tolerance with opiate drugs and can therefore be used to suppress withdrawal symptoms in opiate dependent patients. Methadone is the main treatment offered by the NHS in the UK for opiate dependence. Methadone can be used for both detoxification (if the primary treatment aim is abstinence from opiates), or as a maintenance dose (if the primary treatment aim is harm reduction until the patient is ready to detoxify). In the UK the number of deaths from methadone exceeds the number of deaths from heroin and numbers have increased over the last ten years.(ONS England and Wales: 1993-1997, 220 to 368 deaths from methadone, 55 to 169 deaths from heroin. Curran et.al. (1999) found no sedative, cognitive or psychomotor effects but an increase in craving for opiates in methadone maintenance outpatients, with a 33% increase in their prescribed maintenance dose of methadone. Previous studies have methodological limitations (Zacny, 1995, Weinreib et al, 1993) and inconclusive results. The aim of this study is to investigate the cognitive, psychomotor and mood effects of a 100% increase in methadone dose for opiate dependent in-patients, using a double blind, placebo controlled design, with urinalysis to address some limitations of previous research. A range of measures was used to assess the effects of this increase on cognitive and psychomotor functioning, mood and craving. On admission, participants were stabilised on methadone for 5 days, before the dose is reduced for detoxification in the usual way. Participants were assessed on day 3 and day 5. All participants received their complete dose each day, half the participants received methadone as one whole dose. The others received methadone in a divided dose (50% in the morning, 50% in the evening). The design was balanced for treatment order. Methadone vehicle (linctus) was used as a placebo to maintain double-blind conditions, resulting in the same quantity of linctus administered on each occasion. Both placebo and methadone were flavoured with peppermint so appeared, tasted and smelled the same. Participants were unable to distinguish methadone from placebo. There was no evidence of illicit drug use detected by urinalysis. Results suggest that Methadone has no effect on craving for heroin or mood, but significantly affects delayed recall. The implications of these findings for the treatment of opiate dependency are discussed

    Heroin treatment - new alternative: proceedings of a seminar held on 1 November 1991, Ian Wark Theatre, Backer House, Canberra

    Get PDF
    "So our objective today is to explore the medical, health, social and law enforcement implications of evaluating, in the ACT, new approaches to the treatment of heroin dependent individuals. Drug policy is a highly political issue, any action to change the way we manage drug dependent people in the ACT has political implications for the ACT and for other parts of Australia as well. So I am delighted that we have representatives from drug and law enforcement agencies from most states of Australia here today and that many of the people who will frame attitudes to the proposed ACT trial will have an opportunity to discuss these issues in an open and uninhibited way.at more length later, would involve thoroughly examining the logistic feasibility of the proposed trial. If it was found to be logistically feasible, the third stage would be a small pilot study and only if that was found to work would a trial be conducted." - from Opening Address, Bob Douglas, Director, National Centre for Epidemiology and Population HealthAustralian National University, Australian Institute of Criminology, National Drug & Alcohol Research Centre; National Centre for Epidemiology and Population Healt

    Heroin Treatment - New Alternative : proceedings of a seminar held on 1 November 1991, Ian Wark Theatre, Backer House, Canberra

    Get PDF
    The meeting today grows out of a study conducted jointly by the National Centre for Epidemiology and Population Health and the Australian Institute of Criminology in the early part of this year. That study was prompted by an invitation from the Chairman of the ACT Legislative Assembly’s Select Committee on HIV, Illegal Drugs and Prostitution - Mr Michael Moore - who invited us to examine the feasibility of a trial of the controlled availability of opioids in the ACT. Dr Gabriele Bammer, who directed that investigation, will be setting the scene for us by describing its conclusions at the outset of the day’s discussions. We hope that from that baseline we can move forward in the course of the day to explore the implications of those conclusions and to discuss whether or not it is appropriate to extend the feasibility study to the next stage. So our objective today is to explore the medical, health, social and law enforcement implications of evaluating, in the ACT, new approaches to the treatment of heroin dependent individuals. Drug policy is a highly political issue, any action to change the way we manage drug dependent people in the ACT has political implications for the ACT and for other parts of Australia as well. So I am delighted that we have representatives from drug and law enforcement agencies from most states of Australia here today and that many of the people who will frame attitudes to the proposed ACT trial will have an opportunity to discuss these issues in an open and uninhibited way.The meeting has been assisted by a grant from the ACT Government

    The relation of socioeconomic and cognitive variables to dropout from a Salvation Army Drug Rehabilitation program

    Full text link
    A group of 134 substance abusers from two Salvation Army Rehabilitation programs: the CDIP (Chemical Dependency Intervention Program) and the CDRP (Chemical Dependency Rehabilitation Program) were administered at intake to the program a demographic form, the CMRS (Circumstances, Motivation, Readiness and Suitability Scales), the Novaco Provocation Inventory (NPI) and the Cognitive Triad Inventory (CTI). A stepwise hierarchical analysis for each treatment was used to test the hypothesis asserts that the addition of cognitive factors would improve the prediction rate of dropout using demographic variables alone. Results supported this for the CDIP, but not the CDRP. The second hypothesis was that clients in the program would have elevated levels of NPI and CTI scores as compared to a normative population, which was confirmed by study. The third hypothesis that anger provocability as measured by the NPI would be correlated with the CTI was not supported

    The role of emotions and physiological arousal in modulating impulsive behaviour.

    Get PDF
    Impulsivity received considerable attention in the context of drug misuse and certain neuropsychiatric conditions. Because of its great health and well-being importance, it is crucial to understand factors which modulate impulsive behaviour. As a growing body of literature indicates the role of emotional and physiological states in guiding our actions and decisions, we argue that current affective state and physiological arousal exert a significant influence on behavioural impulsivity. As 'impulsivity' is a heterogeneous concept, in this paper, we review key theories of the topic and summarise information about distinct impulsivity subtypes and their methods of assessment, pointing out to the differences between the various components of the construct. Moreover, we review existing literature on the relationship between emotional states, arousal and impulsive behaviour and suggest directions for future research

    What are the impacts when primary care providers diminish stigma for patients with opioid use disorder in British Columbia?

    Get PDF
    Stigma is a complex phenomenon with a myriad of detrimental health and social impacts that are not fully studied or understood. Persistent stigma exists towards individuals who have opioid use disorder (OUD) in British Columbia. OUD is a chronic, relapsing, clinical condition that has been identified as one of the most challenging substance use disorders. For those affected, they must also endure the consequences of stigma that promote barriers to health care, health and social inequalities, diminished quality of life as well as increased morbidity and mortality. The current unremitting opioid overdose crisis in British Columbia further emphasizes the importance of eradicating stigma towards individuals who use opioids and/or suffer from OUD, as untreated OUD is fueling this multifaceted public health emergency. For these reasons, an integrative literature review has been conducted to identify how primary care providers in British Columbia can address the intersecting stigmas for individuals suffering OUD. The results are discussed within the context of primary health care in British Columbia. Whittemore and Knafl’s approach to the integrative literature review was utilized in this study to review eleven pertinent articles. The findings suggest that stigma occurs on varying levels for individuals with OUD that serve to reinforce each other and manifest as discrimination, mistrust, social distancing, minimized advocacy, unequal access to health care and suboptimal health care. Further, the findings indicated that the role of primary care providers may be instrumental in eradicating stigma in a timely manner. Recommendations for primary care providers to dismantle the stigma associated with OUD are discussed, and specific strategies for the primary care setting are presented.Opioid use disorderStigmaDiscriminationPrimary health carePrimary care provide
    • …
    corecore